alk-positive nsclc: the role of treatment selection and sequencing
Published 5 years ago • 369 plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
1:42
next-generation alk inhibitors: treatment sequencing and resistance
-
2:10
molecularly-guided treatment of advanced nsclc: alk inhibitor sequencing
-
54:12
alk positive summit 2022: current standards of care and treatment philosophies
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
1:15:42
alk 101 part 5: life after lorlatinib
-
3:28
living with alk-positive lung cancer. a patient’s perspective.
-
10:06
똑똑한 암세포 잡는 표적항암제 총정리 - 연세암병원 종양내과 임선민 교수
-
6:27
alk inhibitor sequencing in nsclc
-
4:23
alecensa: targeted therapy for alk-positive lung cancer
-
2:37
crown: lorlatinib in treatment-naïve patients with alk-positive advanced nsclc
-
0:58
progress in the treatment of alk-positive non-small cell lung cancer
-
2:21
current treatment landscape for alk-positive nsclc
-
9:53
sequencing therapy in alk nsclc
-
1:02
blood tests for identifying and monitoring alk-positive non-small cell lung cancer
-
1:21
nice approval of brigatinib in alk-positive nsclc
-
6:36
sequencing strategies for alk-targeted therapy
-
1:42
dr. velcheti on potential of alectinib in frontline alk-positive nsclc
-
0:41
dr. gandhi discusses the role of alectinib in alk lung cancer
-
1:39
key findings of the alex study: improved therapeutic options for alk-positive nsclc
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
3:53
how to maximize clinical benefits for patients with alk-positive non-small cell lung cancer